US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 13.080
  • +0.100+0.77%
Close Jul 16 16:00 ET
  • 13.080
  • 0.0000.00%
Post 16:03 ET
573.98MMarket Cap-26693P/E (TTM)

Y-mAbs Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
25.97%-75.92M
74.42%-8.66M
-6.41%-19.24M
-23.16%-23.1M
Net income from continuing operations
-3.74%-6.63M
77.58%-21.43M
-185.39%-988K
71.86%-7.75M
84.68%-6.3M
77.23%-6.39M
-72.90%-95.57M
103.14%1.16M
4.62%-27.53M
-79.32%-41.13M
Operating gains losses
207.89%492K
-135.20%-1.26M
-635.54%-890K
-79.39%405K
-122.36%-318K
-246.62%-456K
88.56%3.58M
-110.56%-121K
725.63%1.97M
1,723.08%1.42M
Depreciation and amortization
-12.64%159K
-12.40%735K
-30.00%161K
-25.66%168K
19.15%224K
-6.67%182K
7.29%839K
-20.96%230K
55.86%226K
-12.96%188K
Change In working capital
88.57%-1.35M
-90.28%-19.73M
29.87%-9.44M
24.18%3.43M
-170.09%-1.95M
-379.38%-11.76M
-42.38%-10.37M
-306.15%-13.46M
-49.82%2.76M
396.60%2.79M
-Change in receivables
130.24%1.87M
-105.91%-9.92M
-9.15%-3.58M
111.94%244K
-119.66%-416K
-282.82%-6.17M
37.51%-4.82M
-632.14%-3.28M
-263.05%-2.04M
183.97%2.12M
-Change in inventory
-50.82%-3.38M
237.56%1.64M
545.22%2.05M
-448.91%-1.93M
411.61%3.76M
-2,851.32%-2.24M
78.41%-1.19M
36.55%-460K
157.08%552K
57.16%-1.21M
-Change in payables and accrued expense
-25.37%-2.62M
-211.86%-4.65M
65.77%-2.18M
-58.20%1M
-247.92%-1.39M
-236.36%-2.09M
-126.82%-1.49M
-769.30%-6.37M
-46.91%2.4M
-69.35%939K
-Change in other current assets
321.33%2.79M
-136.76%-6.8M
-70.62%-5.73M
122.08%4.1M
-516.08%-3.91M
45.13%-1.26M
-863.30%-2.87M
-8.60%-3.36M
168.60%1.85M
-29.45%939K
Cash from discontinued investing activities
Operating cash flow
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
25.97%-75.92M
74.42%-8.66M
-6.41%-19.24M
-23.16%-23.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
----
----
--0
--0
--0
----
----
--0
Financing cash flow
Cash flow from continuing financing activities
588K
19.05%100K
100K
0
0
0
-99.92%84K
0
-79.03%52K
0
Proceeds from stock option exercised by employees
--588K
19.05%100K
--100K
--0
--0
--0
-85.74%84K
--0
-79.03%52K
--0
Cash from discontinued financing activities
Financing cash flow
--588K
19.05%100K
--100K
--0
--0
--0
-99.92%84K
--0
-79.03%52K
--0
Net cash flow
Beginning cash position
-25.65%78.64M
-41.75%105.76M
-24.41%86.57M
-34.23%87.91M
-40.90%92.63M
-41.75%105.76M
58.39%181.56M
-46.91%114.53M
-42.78%133.67M
-37.87%156.72M
Current changes in cash
77.99%-2.89M
64.22%-27.13M
8.37%-7.94M
93.03%-1.34M
79.51%-4.73M
47.28%-13.12M
-213.53%-75.84M
74.69%-8.66M
-7.17%-19.18M
-23.75%-23.1M
Effect of exchange rate changes
111.11%1K
-80.00%7K
101.94%2K
--0
-65.85%14K
-116.98%-9K
-72.87%35K
-298.08%-103K
4.76%44K
327.78%41K
End cash Position
-18.22%75.75M
-25.65%78.64M
-25.65%78.64M
-24.41%86.57M
-34.23%87.91M
-40.90%92.63M
-41.75%105.76M
-41.75%105.76M
-46.91%114.53M
-42.78%133.67M
Free cash flow
73.51%-3.48M
64.13%-27.23M
7.22%-8.04M
93.04%-1.34M
79.51%-4.73M
47.35%-13.12M
26.66%-75.92M
74.76%-8.66M
-6.00%-19.24M
-22.89%-23.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M25.97%-75.92M74.42%-8.66M-6.41%-19.24M-23.16%-23.1M
Net income from continuing operations -3.74%-6.63M77.58%-21.43M-185.39%-988K71.86%-7.75M84.68%-6.3M77.23%-6.39M-72.90%-95.57M103.14%1.16M4.62%-27.53M-79.32%-41.13M
Operating gains losses 207.89%492K-135.20%-1.26M-635.54%-890K-79.39%405K-122.36%-318K-246.62%-456K88.56%3.58M-110.56%-121K725.63%1.97M1,723.08%1.42M
Depreciation and amortization -12.64%159K-12.40%735K-30.00%161K-25.66%168K19.15%224K-6.67%182K7.29%839K-20.96%230K55.86%226K-12.96%188K
Change In working capital 88.57%-1.35M-90.28%-19.73M29.87%-9.44M24.18%3.43M-170.09%-1.95M-379.38%-11.76M-42.38%-10.37M-306.15%-13.46M-49.82%2.76M396.60%2.79M
-Change in receivables 130.24%1.87M-105.91%-9.92M-9.15%-3.58M111.94%244K-119.66%-416K-282.82%-6.17M37.51%-4.82M-632.14%-3.28M-263.05%-2.04M183.97%2.12M
-Change in inventory -50.82%-3.38M237.56%1.64M545.22%2.05M-448.91%-1.93M411.61%3.76M-2,851.32%-2.24M78.41%-1.19M36.55%-460K157.08%552K57.16%-1.21M
-Change in payables and accrued expense -25.37%-2.62M-211.86%-4.65M65.77%-2.18M-58.20%1M-247.92%-1.39M-236.36%-2.09M-126.82%-1.49M-769.30%-6.37M-46.91%2.4M-69.35%939K
-Change in other current assets 321.33%2.79M-136.76%-6.8M-70.62%-5.73M122.08%4.1M-516.08%-3.91M45.13%-1.26M-863.30%-2.87M-8.60%-3.36M168.60%1.85M-29.45%939K
Cash from discontinued investing activities
Operating cash flow 73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M25.97%-75.92M74.42%-8.66M-6.41%-19.24M-23.16%-23.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0----------0--0--0----------0
Financing cash flow
Cash flow from continuing financing activities 588K19.05%100K100K000-99.92%84K0-79.03%52K0
Proceeds from stock option exercised by employees --588K19.05%100K--100K--0--0--0-85.74%84K--0-79.03%52K--0
Cash from discontinued financing activities
Financing cash flow --588K19.05%100K--100K--0--0--0-99.92%84K--0-79.03%52K--0
Net cash flow
Beginning cash position -25.65%78.64M-41.75%105.76M-24.41%86.57M-34.23%87.91M-40.90%92.63M-41.75%105.76M58.39%181.56M-46.91%114.53M-42.78%133.67M-37.87%156.72M
Current changes in cash 77.99%-2.89M64.22%-27.13M8.37%-7.94M93.03%-1.34M79.51%-4.73M47.28%-13.12M-213.53%-75.84M74.69%-8.66M-7.17%-19.18M-23.75%-23.1M
Effect of exchange rate changes 111.11%1K-80.00%7K101.94%2K--0-65.85%14K-116.98%-9K-72.87%35K-298.08%-103K4.76%44K327.78%41K
End cash Position -18.22%75.75M-25.65%78.64M-25.65%78.64M-24.41%86.57M-34.23%87.91M-40.90%92.63M-41.75%105.76M-41.75%105.76M-46.91%114.53M-42.78%133.67M
Free cash flow 73.51%-3.48M64.13%-27.23M7.22%-8.04M93.04%-1.34M79.51%-4.73M47.35%-13.12M26.66%-75.92M74.76%-8.66M-6.00%-19.24M-22.89%-23.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg